How will COVID-19 affect children in low to middle-income countries?

Global experience to date suggests that the COVID-19 mortality rate for children will be low, even in low to middle-income countries. However, modelling published this month in the Lancet indicates that there will be a considerable indirect impact. COVID-19 will weaken, and in some cases overwhelm, health systems which will lead to a reduction in […]

Top 5 Achievements for 2019

2009’s top 10 | 2010’s top 10 | 2011’s  top 10 | 2012’s top 10 | 2013’s top 10 2014’s top 10 | 2015’s top 10 | 2016’s top 10 | 2017’s top 10 | 2018’s top 10   We’ve had 10 years of Top Tens: an exciting decade when ColaLife achieved much more than we ever expected. 2019 […]

The role of innovation in augmenting Healthcare – the ColaLife Story

I have spent the last two days (27 to 28-Nov-19) at the Africa Health Extension Summit (#AHES19) in Nairobi where I told an abbreviated version of the ColaLife story to illustrate the role of innovation in improving healthcare. Key themes were: why we need innovation in the healthcare sector what we mean by innovation how […]

Success: WHO adds co-packaged ORS and zinc to its Essential Medicines List

Our application* to get co-packaged ORS and zinc on the WHO Essential Medicines List has been successful. This is game-changer. It moves ColaLife’s work out of the ‘innovation box’ into the mainstream of global children’s public health – with better designed, easier-to-dispense diarrhoea treatment available for sick children – potentially everywhere. The WHO Essential Medicines […]

MSF writes letter of support for our application to get co-packaged ORS and zinc on the WHO Essential Medicines List

It was drawn to my attention just yesterday (15-May-19) that MSF (Médecins Sans Frontières) wrote a strong letter of support for our application to get co-packaged ORS and zinc on the WHO Essential Medicines List. I approached MSF, like others, before we lodged the application but they declined saying that they would assess the application […]

Our EML application now open for comments on the WHO website

Our application to get co-packaged ORS and zinc on the WHO Model Essential Medicines List for Children (EMLc) is now open for comments on the WHO website here. Our application can be downloaded from this link and comments, including letters of support, should be sent to: emlsecretariat@who.int. Our application has eleven letters of support so far from […]

Top 10 achievements in 2018

2009’s top 10 | 2010’s top 10 | 2011’s  top 10 | 2012’s top 10 | 2013’s top 10 2014’s top 10 | 2015’s top 10 | 2016’s top 10 | 2017’s top 10 2018 saw us move from self-sustaining development in Zambia towards the globalisation of our work. The cover page of our application to the World Health […]

DfID Secretary of State and UNICEF provide letters of support

On 12-Nov-18 we submitted our application to WHO to add co-packaged ORS and zinc to the WHO Essential Medicines List for Children and this was reported here. Our application was submitted with ten letters of support. The application and the letters of support are now available on the WHO website here. Letters of support have […]

Update 2: Co-packaged ORS/Zinc on the WHO Essential Medicines List for Children (EMLc)

We met with WHO representatives on 25-Jun-18 in Geneva to discuss our application It’s a year since I last updated you on our progress towards getting co-packaged ORS and zinc on WHO’s Essential Medicines List for Children (EML). You can read the last update here. In summary, a lot of progress has been made and […]

We’ve got designs on change: 1 – Findings from our endline household survey (KYTS-ACE)

This may be a bit of a technical post, but it answers the very simple question at the heart of our work: ‘Can design improve health outcomes for children?’ We think the answer is YES.  Here is some of our emerging evidence – see if you agree! When we began work to save children’s lives by improving […]